Efthymios N. Deliargyris
2022
In 2022, Efthymios N. Deliargyris earned a total compensation of $1M as Chief Medical Officer at Cytosorbents, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $42,547 |
|---|---|
| Option Awards | $443,863 |
| Salary | $408,100 |
| Stock Awards | $101,400 |
| Other | $12,500 |
| Total | $1,008,410 |
Deliargyris received $443.9K in option awards, accounting for 44% of the total pay in 2022.
Deliargyris also received $42.5K in bonus, $408.1K in salary, $101.4K in stock awards and $12.5K in other compensation.
Rankings
In 2022, Efthymios N. Deliargyris' compensation ranked 3,014th out of 5,760 executives tracked by ExecPay. In other words, Deliargyris earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,014 out of 5,760 | 48th |
Division Manufacturing | 1,691 out of 3,136 | 46th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 204 out of 485 | 58th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 138 out of 347 | 60th |
Industry Surgical and Medical Instruments and Apparatus | 114 out of 253 | 55th |
Source: SEC filing on April 21, 2023.
Deliargyris' colleagues
We found three more compensation records of executives who worked with Efthymios N. Deliargyris at Cytosorbents in 2022.